New Gene Expression Analysis from Ongoing Phase 2 Study Provides Strong Biomarker Evidence that Treatment with TFF TAC Results in […]
BEDFORD, Mass., April 15, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s […]
HOUSTON, April 15, 2024 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery […]
ORLANDO, FL, April 15, 2024 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global […]
Mobilicom is a member of The Association for Uncrewed Vehicle Systems International’s (AUVSI) Cybersecurity Working Group and is highly regarded […]
WATERTOWN, Mass., April 15, 2024 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics […]
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated […]
SHENZHEN, China, April 15, 2024 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading […]
WILMINGTON, Del., April 15, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and […]
NEWTOWN, PA, April 14, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Forian Inc. (Nasdaq:FORA), a provider of data science driven information […]
